In conclusion, overexpression of a non-cytotoxic amylin agonist in the L44 transgenic line causes obesity, hyperinsulinaemia, perturbed metabolic hormone signalling in the brain, and overt diabetes. The gene discussed is IAPP; the disease is diabetes mellitus.